What’s New

Characteristics of COVID-19 patients in China

Researchers examined the clinical characteristics of 1,099 patients with laboratory-confirmed COVID-19 from China. Source: AAO

Posted on: May 6 2020
By: Saratoga Opthalmology
Leave a response

Vitreous hemorrhage tied to increased risk of epiretinal membrane

This case series examined risk factors, onset timing and progression of epiretinal membrane after pars plana vitrectomy for rhegmatogenous retinal detachment (RRD). Source: AAO

Posted on: May 5 2020
By: Saratoga Opthalmology
Leave a response

In vitro study finds hydroxychloroquine more potent than chloroquine for inhibiting SARS-CoV-2

Scientists compared the pharmacological activity of chloroquine and hydroxychloroquine in cells infected with SARS-CoV-2. Source: AAO

Posted on: May 4 2020
By: Saratoga Opthalmology
Leave a response

Week in review: Blinking device, interstellar retina, reproxalap potential

This week, scientists create a device that mimics human blinking, NASA awards $5 million for retina research and reproxalap is being screened as a possible COVID-19 treatment. Source: AAO

Posted on: May 1 2020
By: Saratoga Opthalmology
Leave a response

Case study links COVID-19 to follicular conjunctivitis

The authors report the ocular characteristics and presence of viral RNA in a patient with COVID-19. Source: AAO

Posted on: May 1 2020
By: Saratoga Opthalmology
Leave a response

New keratoprosthesis device shows promising short-term outcomes

The authors report the short-term outcomes of the new keratoprosthesis device Lux for corneal blindness. Source: AAO

Posted on: Apr 30 2020
By: Saratoga Opthalmology
Leave a response

SARS-CoV-2 can survive up to 3 days on stainless steel and plastic surfaces

The aerosol and surface stability of SARS-CoV-2, the virus that causes COVID-19, was evaluated in this study. Source: AAO

Posted on: Apr 29 2020
By: Saratoga Opthalmology
Leave a response

Orbital radiation plus IV steroids effective for Graves ophthalmopathy

With multiple viable treatments for Graves ophthalmopathy, this network meta-analysis performed on existing research asks what the most efficient and tolerable treatments are. Source: AAO